NASDAQ:FENC

Fennec Pharmaceuticals Short Interest Ratio and Short Volume

$6.17
+0.06 (+0.98 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$5.96
$6.27
50-Day Range
$5.96
$7.23
52-Week Range
$4.80
$10.67
Volume99,049 shs
Average Volume106,291 shs
Market Capitalization$160.44 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07

Short Interest

Fennec Pharmaceuticals (NASDAQ:FENC) Short Interest Data

Current Short Volume1,240,000 shares
Previous Short Volume1,080,000 shares
Change Vs. Previous Month+14.81%
Dollar Volume Sold Short$8.00 million
Short Interest Ratio / Days to Cover0.0
Last Record DateApril, 15 2021
Outstanding Shares26,003,000 shares
Percentage of Shares Shorted4.77%
Today's Trading Volume99,049 shares
Average Trading Volume106,291 shares
Today's Volume Vs. Average-6.81%

Short Interest Over Time


Fennec Pharmaceuticals (NASDAQ:FENC) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20211,240,000 shares $8.00 million +14.8%N/A0$6.45
3/31/20211,080,000 shares $6.97 million +8.0%5.6%10.4$6.45
3/15/20211,000,000 shares $7.70 million +3.3%5.2%12.5$7.70
2/26/2021967,900 shares $7.39 million +6.2%5.0%11.4$7.64
2/12/2021911,300 shares $7.63 million +1.0%4.7%10.1$8.37
1/29/2021902,600 shares $6.64 million -8.2%4.7%8.9$7.36
1/15/2021983,200 shares $7.27 million -1.2%5.1%9.2$7.39
12/31/2020994,700 shares $7.10 million -5.3%5.2%9.2$7.14
12/15/20201,050,000 shares $7.95 million -13.2%5.4%7.9$7.58
11/30/20201,210,000 shares $9.37 million -4.7%6.3%7.5$7.74
11/15/20201,270,000 shares $10.86 million -5.9%6.6%6.7$8.55
10/30/20201,350,000 shares $10.42 million +7.1%7.0%5.2$7.72
10/15/20201,260,000 shares $9.25 million -10.0%6.7%3.2$7.34
9/30/20201,400,000 shares $8.48 million +1.5%7.4%3.4$6.06
9/15/20201,380,000 shares $8.42 million +17.0%7.3%2.9$6.10
8/31/20201,180,000 shares $6.47 million +11.3%6.3%2.5$5.48
8/14/20201,060,000 shares $6.01 million -4.5%5.6%2.4$5.67
7/31/20201,110,000 shares $9.37 million -9.0%5.2%3$8.44
7/15/20201,220,000 shares $10.35 million -10.3%5.7%4.8$8.48
6/30/20201,360,000 shares $11.12 million +164.4%6.4%6$8.18
6/15/2020514,400 shares $4.32 million -6.2%2.4%3.4$8.39
5/29/2020548,400 shares $4.06 million +2.6%2.7%4.5$7.40
5/15/2020534,300 shares $3.92 million -20.7%2.7%4.9$7.34
4/30/2020673,700 shares $4.87 million -2.5%3.4%6.4$7.23
4/15/2020691,100 shares $4.38 million -19.0%4.2%10.1$6.34

Fennec Pharmaceuticals (NASDAQ:FENC) Short Interest FAQ

speech bubbles
speech bubbles











What is Fennec Pharmaceuticals' current short interest?

Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,240,000 shares of FENC short.

Is Fennec Pharmaceuticals' short interest increasing or decreasing?

Fennec Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,240,000 shares, an increase of 14.8% from the previous total of 1,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Fennec Pharmaceuticals' short interest compare to its competitors?

0.00% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: Tarsus Pharmaceuticals, Inc. (4.54%), MeiraGTx Holdings plc (0.00%), Inhibrx, Inc. (3.55%), Poseida Therapeutics, Inc. (9.23%), Solid Biosciences Inc. (0.00%), Compugen Ltd. (0.00%), Precision BioSciences, Inc. (13.93%), Oyster Point Pharma, Inc. (9.95%), Gritstone Oncology, Inc. (0.00%), and Lineage Cell Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.85 billion), Aon plc ($5.61 billion), Charter Communications, Inc. ($5.44 billion), Snap Inc. ($3.49 billion), Airbnb, Inc. ($3.35 billion), Peloton Interactive, Inc. ($2.53 billion), ViacomCBS Inc. ($2.48 billion), Expedia Group, Inc. ($2.39 billion), The Kroger Co. ($2.26 billion), and Nuance Communications, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Fennec Pharmaceuticals stock?

Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. Fennec Pharmaceuticals' stock is trading up $0.06 today. To short Fennec Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Fennec Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fennec Pharmaceuticals?

A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further.

How often is Fennec Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is April, 15 2021.



This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.